U.S. federal trademark · Serial No. 88763664 · Reg. No. 7108233
Biological compound for medical use, namely, enhanced ribonucleic acid delivered into patient cells; Biological compounds being a component in vaccines; Therapeutic agents for generating protective immune response; Molecularly engineered RNA for increasing expression, and extending duration of expression, of therapeutic proteins upon delivery into patient cells
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.